The Evolution of the Antimicrobial Resistance of Streptococcus pneumoniae in Tunisia: A Multicentric Analysis over Two Decades (2000–2019)
Authors:
- Nourelhouda Ben AyedNANourelhouda Ben Ayed
- Omar GargouriOGOmar Gargouri
- Samar MhimdiSMSamar Mhimdi
- Fahmi SmaouiFSFahmi Smaoui
- Emna MhiriEMEmna Mhiri
- Lamia KanzariLKLamia Kanzari
- Meriam ZribiMZMeriam Zribi
- Senda Maalej MezghanniSMSenda Maalej Mezghanni
- Sonia KtariSKSonia Ktari
- Khaoula MeftahKMKhaoula Meftah
- Naglaa MohamedNMNaglaa Mohamed
- Hela ZaghdenHZHela Zaghden
Open Access
- 10 February 2025
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 14 (2) , 171
Abstract
Background/Objectives: Streptococcus pneumoniae is a leading respiratory pathogen responsible for significant morbidity and mortality, particularly among vulnerable populations. Understanding its antimicrobial resistance patterns and serotype distribution is crucial for guiding treatment and prevention strategies. This study aims to examine these trends in S. pneumoniae isolates from Tunisia over a two-decade period (2000–2019). Methods: A retrospective time series analysis was conducted on data (n = 4284) gathered from eight university hospital centers across Tunisia. Antimicrobial susceptibility testing was performed according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines. Pneumococcal serotypes were determined for a subset of samples from 2012 to 2019 (n = 903) using multiplex PCR and latex agglutination. Results: Penicillin G resistance decreased from 9–13.7% during 2000–2002 to 4.3% by 2019, while amoxicillin resistance increased until reaching 10% in 2019. Erythromycin resistance initially increased before stabilizing between 61.9% and 66.3% during 2014–2019, whereas tetracycline resistance declined from 2000 to 2008 and fluctuated around 40% during 2009–2019. Levofloxacin resistance did not exceed 1.2% throughout the study period. The most prevalent serotypes were 14, 19F, 19A, 23F, 3, 6B, 6A, and 9V. Among them, serotype 3 was the most susceptible overall. Serotypes 23F, 14, 9V, and 6B displayed the highest levels of multi-drug resistance. Conclusions: Penicillin G (high-dosage), cefotaxime, and levofloxacin are still effective against most S. pneumoniae strains in Tunisia, while erythromycin and tetracycline are not reliable options for treating pneumococcal infections. Alarming resistance rates among prevalent serotypes, except serotype 3, underscore the need for preventive measures, rational antibiotic use, and ongoing surveillance.Keywords
Funding Information
- Pfizer (82042983)
This publication has 35 references indexed in Scilit:
- Epidemiological characteristics and antibiotic resistance mechanisms of Streptococcus pneumoniae: An updated reviewMicrobiological Research, 2022
- Ceftriaxone versus ampicillin for the treatment of community-acquired pneumonia. A propensity matched cohort studyClinical Microbiology and Infection, 2022
- Factors affecting antimicrobial resistance in Streptococcus pneumoniae following vaccination introductionTrends in Microbiology, 2022
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysisThe Lancet, 2022
- Invasive Streptococcus pneumoniae isolates from pediatric population in Argentina for the period 2006–2019. Temporal progression of serotypes distribution and antibiotic resistanceVaccine, 2022
- National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017–2020Journal of Global Antimicrobial Resistance, 2021
- Clonal lineages and antimicrobial resistance of nonencapsulated Streptococcus pneumoniae in the post-pneumococcal conjugate vaccine era in JapanInternational Journal of Infectious Diseases, 2021
- Genetic diversity of Streptococcus pneumoniae in TunisiaInternational Journal of Antimicrobial Agents, 2019
- Antimicrobial Resistance Among Streptococcus pneumoniae2018
- Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populationsVaccine, 2013